Search Results 411-420 of 17822 for Coagulate

1. https://www.mayoclinic.org/spanish_patient_consumer_recipe.xml

2. A Study of Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with MCL-1 Dependence ≥ 40% - Mayo Clinic

   Have evidence of uncontrolled disseminated intravascular coagulation. Have an active, uncontrolled infection. Have other life-threatening illness. Have ...

3. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy - Mayo Clinic

   Subjects who are therapeutically treated with an agent such as warfarin or heparin will be allowed to participate if no underlying abnormality in coagulation ...

4. https://www.mayoclinic.org/arabic_patient_consumer_recipe.xml

5. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

   Adequate coagulation function as defined by International Normalization ... coagulation factors monitored closely throughout the study. Subjects ...

7. Cardiovascular Medicine - Clinical trials

   [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

8. Mayo Clinic

   An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20129674.

9. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

10. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

    serum creatinine (μmol/L). Meet the following coagulation requirements: For patients not receiving therapeutic anticoagulation: INR or aPTT ≤ 1.5 × ULN ...